Ameliorative Effect of Glycyrrhizic Acid on Diosbulbin B-Induced Liver Injury and Its Mechanism
This study aimed to clarify the protective effect of Glycyrrhizic acid (GL) against Diosbulbin B (DB) - induced liver injury in mice and investigate its mechanisms of action. A liver injury DB was established in mice through the oral administration of DB for 15 days. At the same time, GL was adminis...
Saved in:
| Published in: | The American journal of Chinese medicine (1979) Vol. 53; no. 1; p. 309 |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Singapore
2025
|
| Subjects: | |
| ISSN: | 1793-6853, 1793-6853 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | This study aimed to clarify the protective effect of Glycyrrhizic acid (GL) against Diosbulbin B (DB) - induced liver injury in mice and investigate its mechanisms of action. A liver injury DB was established in mice through the oral administration of DB for 15 days. At the same time, GL was administered to the mice for treatment. After the experiment, the pharmacodynamics and mechanisms of GL in ameliorating DB-induced liver injury were explored using biochemical indexes, non-targeted metabolomics, targeted metabolomics, Western blotting analysis of protein expression, 16S rDNA sequencing, and Spearman correlation analysis. The results show reduced liver function indices and improved DB-induced hepatic pathological changes. It also attenuated DB-induced hepatic inflammation and oxidative stress. Hepatic metabolomics revealed that GL regulated ABC transporters and bile secretion. Targeted bile acid (BA) metabolomics and Western blotting demonstrated that GL improved DB-induced reduction in BA efflux by regulating FXR-mediated efflux transporters. Furthermore, analysis of 16S rDNA gene sequencing revealed that GL effectively restored the relative abundance of beneficial bacteria, reduced the relative abundance of harmful bacteria, and reinstated the structure of the intestinal flora. Additionally, correlation analyses between BA and intestinal flora indicated that
, TDGA, DGA, UDGA, GDGA, THDGA, and HDGA could serve as major markers for DB-induced liver injury. In conclusion, GL significantly improved DB-induced liver injury by increasing the expression of Nrf2/FXR-BSEP/MRP2/P-gp/UGT1A1, promoting BA efflux, regulating intestinal flora, and alleviating inflammation and oxidative stress. |
|---|---|
| AbstractList | This study aimed to clarify the protective effect of Glycyrrhizic acid (GL) against Diosbulbin B (DB) - induced liver injury in mice and investigate its mechanisms of action. A liver injury DB was established in mice through the oral administration of DB for 15 days. At the same time, GL was administered to the mice for treatment. After the experiment, the pharmacodynamics and mechanisms of GL in ameliorating DB-induced liver injury were explored using biochemical indexes, non-targeted metabolomics, targeted metabolomics, Western blotting analysis of protein expression, 16S rDNA sequencing, and Spearman correlation analysis. The results show reduced liver function indices and improved DB-induced hepatic pathological changes. It also attenuated DB-induced hepatic inflammation and oxidative stress. Hepatic metabolomics revealed that GL regulated ABC transporters and bile secretion. Targeted bile acid (BA) metabolomics and Western blotting demonstrated that GL improved DB-induced reduction in BA efflux by regulating FXR-mediated efflux transporters. Furthermore, analysis of 16S rDNA gene sequencing revealed that GL effectively restored the relative abundance of beneficial bacteria, reduced the relative abundance of harmful bacteria, and reinstated the structure of the intestinal flora. Additionally, correlation analyses between BA and intestinal flora indicated that Firmicutes, Bacteroidota, TDGA, DGA, UDGA, GDGA, THDGA, and HDGA could serve as major markers for DB-induced liver injury. In conclusion, GL significantly improved DB-induced liver injury by increasing the expression of Nrf2/FXR-BSEP/MRP2/P-gp/UGT1A1, promoting BA efflux, regulating intestinal flora, and alleviating inflammation and oxidative stress.This study aimed to clarify the protective effect of Glycyrrhizic acid (GL) against Diosbulbin B (DB) - induced liver injury in mice and investigate its mechanisms of action. A liver injury DB was established in mice through the oral administration of DB for 15 days. At the same time, GL was administered to the mice for treatment. After the experiment, the pharmacodynamics and mechanisms of GL in ameliorating DB-induced liver injury were explored using biochemical indexes, non-targeted metabolomics, targeted metabolomics, Western blotting analysis of protein expression, 16S rDNA sequencing, and Spearman correlation analysis. The results show reduced liver function indices and improved DB-induced hepatic pathological changes. It also attenuated DB-induced hepatic inflammation and oxidative stress. Hepatic metabolomics revealed that GL regulated ABC transporters and bile secretion. Targeted bile acid (BA) metabolomics and Western blotting demonstrated that GL improved DB-induced reduction in BA efflux by regulating FXR-mediated efflux transporters. Furthermore, analysis of 16S rDNA gene sequencing revealed that GL effectively restored the relative abundance of beneficial bacteria, reduced the relative abundance of harmful bacteria, and reinstated the structure of the intestinal flora. Additionally, correlation analyses between BA and intestinal flora indicated that Firmicutes, Bacteroidota, TDGA, DGA, UDGA, GDGA, THDGA, and HDGA could serve as major markers for DB-induced liver injury. In conclusion, GL significantly improved DB-induced liver injury by increasing the expression of Nrf2/FXR-BSEP/MRP2/P-gp/UGT1A1, promoting BA efflux, regulating intestinal flora, and alleviating inflammation and oxidative stress. This study aimed to clarify the protective effect of Glycyrrhizic acid (GL) against Diosbulbin B (DB) - induced liver injury in mice and investigate its mechanisms of action. A liver injury DB was established in mice through the oral administration of DB for 15 days. At the same time, GL was administered to the mice for treatment. After the experiment, the pharmacodynamics and mechanisms of GL in ameliorating DB-induced liver injury were explored using biochemical indexes, non-targeted metabolomics, targeted metabolomics, Western blotting analysis of protein expression, 16S rDNA sequencing, and Spearman correlation analysis. The results show reduced liver function indices and improved DB-induced hepatic pathological changes. It also attenuated DB-induced hepatic inflammation and oxidative stress. Hepatic metabolomics revealed that GL regulated ABC transporters and bile secretion. Targeted bile acid (BA) metabolomics and Western blotting demonstrated that GL improved DB-induced reduction in BA efflux by regulating FXR-mediated efflux transporters. Furthermore, analysis of 16S rDNA gene sequencing revealed that GL effectively restored the relative abundance of beneficial bacteria, reduced the relative abundance of harmful bacteria, and reinstated the structure of the intestinal flora. Additionally, correlation analyses between BA and intestinal flora indicated that , TDGA, DGA, UDGA, GDGA, THDGA, and HDGA could serve as major markers for DB-induced liver injury. In conclusion, GL significantly improved DB-induced liver injury by increasing the expression of Nrf2/FXR-BSEP/MRP2/P-gp/UGT1A1, promoting BA efflux, regulating intestinal flora, and alleviating inflammation and oxidative stress. |
| Author | Shi, Lei-Lei Shangguan, Hui-Zi Wang, Xin Xie, Yun-Dong Zhu, Hong-Zhe Cao, Shan-Shan Liu, Ji-Ping Shi, Yong Zhang, Yu-Han |
| Author_xml | – sequence: 1 givenname: Xin orcidid: 0009-0003-3365-1141 surname: Wang fullname: Wang, Xin organization: Department of Pharmacology, Shaanxi University of Chinese Medicine, No. 1, Middle Section of Century Avenue, Xianyang 712046, P. R. China – sequence: 2 givenname: Lei-Lei orcidid: 0009-0003-5902-7232 surname: Shi fullname: Shi, Lei-Lei organization: Department of Pharmacology, Shaanxi University of Chinese Medicine, No. 1, Middle Section of Century Avenue, Xianyang 712046, P. R. China – sequence: 3 givenname: Yu-Han orcidid: 0009-0004-3551-6178 surname: Zhang fullname: Zhang, Yu-Han organization: Department of Pharmacology, Shaanxi University of Chinese Medicine, No. 1, Middle Section of Century Avenue, Xianyang 712046, P. R. China – sequence: 4 givenname: Hong-Zhe orcidid: 0009-0003-0709-2454 surname: Zhu fullname: Zhu, Hong-Zhe organization: Department of Pharmacology, Shaanxi University of Chinese Medicine, No. 1, Middle Section of Century Avenue, Xianyang 712046, P. R. China – sequence: 5 givenname: Shan-Shan orcidid: 0009-0003-4608-7498 surname: Cao fullname: Cao, Shan-Shan organization: Department of Pharmacology, Shaanxi University of Chinese Medicine, No. 1, Middle Section of Century Avenue, Xianyang 712046, P. R. China – sequence: 6 givenname: Yong orcidid: 0009-0004-3928-743X surname: Shi fullname: Shi, Yong organization: Department of Pharmacology, Shaanxi University of Chinese Medicine, No. 1, Middle Section of Century Avenue, Xianyang 712046, P. R. China – sequence: 7 givenname: Hui-Zi orcidid: 0009-0001-5940-2392 surname: Shangguan fullname: Shangguan, Hui-Zi organization: Department of Pharmacology, Shaanxi University of Chinese Medicine, No. 1, Middle Section of Century Avenue, Xianyang 712046, P. R. China – sequence: 8 givenname: Ji-Ping orcidid: 0000-0001-8138-9561 surname: Liu fullname: Liu, Ji-Ping organization: Shaanxi Key Laboratory for Safety Monitoring of Food and Drug, Xianyang 712046, P. R. China – sequence: 9 givenname: Yun-Dong orcidid: 0009-0008-9358-4864 surname: Xie fullname: Xie, Yun-Dong organization: Department of Pharmacology, Shaanxi University of Chinese Medicine, No. 1, Middle Section of Century Avenue, Xianyang 712046, P. R. China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39829229$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNUM1LwzAcDTJxH_oHeJEcvVSbpFnS49Q5CxMPKngrSfoLy2jTmbRC_estOMHTe_A-4L05mvjWA0KXJL0hJKO3rynJaUb4B-U8TQlNT9CMiJwlS8nZ5B-fonmM-9HChFyeoSnLJc0pzWeoXDVQuzaozn0BXlsLpsOtxZt6MEMIO_ftDF4ZV-HW4wfXRt3X2nl8lxS-6g1UeDsGAy78vg8DVr7CRRfxM5id8i425-jUqjrCxREX6P1x_Xb_lGxfNsX9apsYRrIuMUvOQUmriRWaKhCaZFKnAnTOLXDG2YgagOhKSCsYlVJRgGWeGZuNCl2g69_eQ2g_e4hd2bhooK6Vh7aPJSNcjCdl4_AFujpae91AVR6Ca1QYyr9T6A872maN |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1142/S0192415X25500120 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1793-6853 |
| ExternalDocumentID | 39829229 |
| Genre | Journal Article |
| GroupedDBID | --- .GJ 0R~ 123 23M 36B 4.4 53G 5RE 6J9 6NX 6PF AAWTL ADSJI AEGXH AENEX AFOSN AIZAD ALMA_UNASSIGNED_HOLDINGS C1A CAG CGR COF CS3 CUY CVF EBS ECM ECV EIF EJD EMOBN F5P FAL FEDTE FJD FJW HVGLF HZ~ NPM O9- P2P P71 PQQKQ RWJ WH7 WQ9 WSL ZGI ZXP 7X8 |
| ID | FETCH-LOGICAL-c314t-c655ea8fb1f7b2ae7b148b07eb95fe535395fbee1bd78f73288a2ee694cf45fb2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 3 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001399109900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1793-6853 |
| IngestDate | Thu Oct 02 05:40:46 EDT 2025 Sat May 03 02:01:26 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Diosbulbin B Bile Acid Glycyrrhizic Acid Hepatotoxicity Intestinal Flora |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c314t-c655ea8fb1f7b2ae7b148b07eb95fe535395fbee1bd78f73288a2ee694cf45fb2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0009-0003-4608-7498 0009-0001-5940-2392 0000-0001-8138-9561 0009-0003-3365-1141 0009-0004-3551-6178 0009-0004-3928-743X 0009-0008-9358-4864 0009-0003-5902-7232 0009-0003-0709-2454 |
| PMID | 39829229 |
| PQID | 3157550498 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_3157550498 pubmed_primary_39829229 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-00-00 20250101 |
| PublicationDateYYYYMMDD | 2025-01-01 |
| PublicationDate_xml | – year: 2025 text: 2025-00-00 |
| PublicationDecade | 2020 |
| PublicationPlace | Singapore |
| PublicationPlace_xml | – name: Singapore |
| PublicationTitle | The American journal of Chinese medicine (1979) |
| PublicationTitleAlternate | Am J Chin Med |
| PublicationYear | 2025 |
| SSID | ssj0013786 |
| Score | 2.3974392 |
| Snippet | This study aimed to clarify the protective effect of Glycyrrhizic acid (GL) against Diosbulbin B (DB) - induced liver injury in mice and investigate its... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 309 |
| SubjectTerms | Animals ATP-Binding Cassette Transporters - metabolism Bile Acids and Salts - metabolism Chemical and Drug Induced Liver Injury - drug therapy Chemical and Drug Induced Liver Injury - etiology Chemical and Drug Induced Liver Injury - metabolism Disease Models, Animal Gastrointestinal Microbiome - drug effects Glycyrrhizic Acid - administration & dosage Glycyrrhizic Acid - pharmacology Glycyrrhizic Acid - therapeutic use Heterocyclic Compounds, 4 or More Rings - adverse effects Liver - drug effects Liver - metabolism Liver - pathology Male Mice Oxidative Stress - drug effects |
| Title | Ameliorative Effect of Glycyrrhizic Acid on Diosbulbin B-Induced Liver Injury and Its Mechanism |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/39829229 https://www.proquest.com/docview/3157550498 |
| Volume | 53 |
| WOSCitedRecordID | wos001399109900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7Uinjx_agvVvC61Gw2r5PUd8EWQYXewu5mFiNtUptWqL_e2SRFL4LgJTmEQJiZzHzz2G8IOcOgBeD7hkntBUz4QjKpTMQwuAOag0bHWfLMPgS9XtjvR491wa2oxyrnPrF01EmubY285ToILDzEs-HF6J3ZrVG2u1qv0FgkDRehjB3pCvo_ughBuenR2iDzMS7VXU1H8NaThTYYvPoIqcsDpL8jzDLS3K7_9xs3yFqNMWm7MopNsgDZFlnp1l30bRK3hzBI84rzm1b8xTQ39G4w07Px-DX9TDVt6zSheUav07xQ0wEm0PSS2UUfGhL6YKc5aCd7Q41QmSW0MyloF-wp4rQY7pCX25vnq3tWL1pg2nXEhGnf80CGRjkmUFxCoDBJUucBqMgz4Lmei3cF4KgkCI2l9wklRxVHQhuBT_guWcryDPYJTbQQlhHHTyASKuFSQYgZpvK1g1BRRk1yOhddjIZsuxMyg3xaxN_Ca5K9Sv7xqGLciFG1POI8OvjD24dkldsdvWWZ5Ig0DP7GcEyW9cckLcYnpYXgtffY_QKQl8V0 |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ameliorative+Effect+of+Glycyrrhizic+Acid+on+Diosbulbin+B-Induced+Liver+Injury+and+Its+Mechanism&rft.jtitle=The+American+journal+of+Chinese+medicine+%281979%29&rft.au=Wang%2C+Xin&rft.au=Shi%2C+Lei-Lei&rft.au=Zhang%2C+Yu-Han&rft.au=Zhu%2C+Hong-Zhe&rft.date=2025-01-01&rft.issn=1793-6853&rft.eissn=1793-6853&rft.volume=53&rft.issue=1&rft.spage=309&rft_id=info:doi/10.1142%2FS0192415X25500120&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1793-6853&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1793-6853&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1793-6853&client=summon |